Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis

Steven L. Truong, Jasmine Chin, David F. L. Liew, Syeda Farah Zahir, Elizabeth G. Ryan, Diana Rubel, Graham Radford-Smith, Philip C. Robinson

Open source

DOI
10.1007/s40744-021-00360-6
Published
2021-08-26
Container
Rheumatology and Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40744-021-00360-6,
  title = {Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis},
  author = {Steven L. Truong and Jasmine Chin and David F. L. Liew and Syeda Farah Zahir and Elizabeth G. Ryan and Diana Rubel and Graham Radford-Smith and Philip C. Robinson},
  year = {2021},
  journal = {Rheumatology and Therapy},
  doi = {10.1007/s40744-021-00360-6},
  url = {https://doi.org/10.1007/s40744-021-00360-6}
}

RIS

TY  - JOUR
TI  - Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis
AU  - Steven L. Truong
AU  - Jasmine Chin
AU  - David F. L. Liew
AU  - Syeda Farah Zahir
AU  - Elizabeth G. Ryan
AU  - Diana Rubel
AU  - Graham Radford-Smith
AU  - Philip C. Robinson
PY  - 2021
JO  - Rheumatology and Therapy
DO  - 10.1007/s40744-021-00360-6
UR  - https://doi.org/10.1007/s40744-021-00360-6
ER  - 

APA

Truong, S. L., Chin, J., Liew, D. F. L., Zahir, S. F., Ryan, E. G., Rubel, D., Radford-Smith, G., & Robinson, P. C. (2021). Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis. Rheumatology and Therapy. https://doi.org/10.1007/s40744-021-00360-6

Source records